SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 200.79-0.2%Nov 14 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Night Trader who wrote (15002)2/13/1998 3:08:00 PM
From: Wallace Rivers  Read Replies (1) of 32384
 
As one who was a broker and is a current money manager, while a complete idiot on bioscience, let me add something of substance to this thread concerning WS coverage. Coverage begins BEFORE secondary offerings (and those participating in the secondary provide research coverage), because WS firms make big bucks from banking business. Typically, WS likes to juice up a stock prior to the secondary, so more $$ can be brought in. The secondary gets done, the company and the bankers are joyous, positive research continues, and the stock hopefully continues to rise, making buyers on the secondary happy, as well. Not a formula cast in stone, but one I have seen repeated many times.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext